{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-074577","form_type":"8-K","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2026-06-16T20:06:02+00:00","discovered_at":"2026-06-16T20:08:00.329597+00:00","generated_at":"2026-06-16T20:08:52.567048+00:00","sec_items":[],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Century Therapeutics CSO Chad Cowan moves to part-time with reduced salary","bullets":["Chad Cowan continues as CSO on part-time basis; salary cut to $296,150 annually.","Eligible for pro-rated annual performance-based target bonus.","Upon company termination or resignation, entitled only to accrued unpaid base salary.","A&R Employment Agreement to be filed as exhibit to Q2 2026 10-Q.","Agreement effective June 15, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-074577","json":"https://secwatch.observer/filing/0001104659-26-074577.json","markdown":"https://secwatch.observer/filing/0001104659-26-074577.md","text":"https://secwatch.observer/filing/0001104659-26-074577.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465926074577/0001104659-26-074577-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465926074577/tm2617925d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T20:08:52.567048+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}